Skip to main content

Table 2 Characteristics of pemphigoid disease-related substrates used in the BIOCHIP mosaic

From: Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy

Disease

BP180-NC16A-4X

BP230gC

Bullous pemphigoid

42/42

23/42

 Sensitivity

100%

54.8%

 95%CI

91.6-100%

38.7-70.2%

 Specificity

98.2%

100%

 95%CI

96.7-99.3%

98.9-100%

Pemphigus vulgaris

0/65

0/65

Pemphigus foliaceus

0/50

0/50

Linear IgA disease

0/18

0/18

HBD

1/100

0/100

NISD

7/97

0/97

  1. BP230gC, c-terminal globular domain of BP230; HBD, healthy blood donors; NISD, non-inflammatory skin diseases; 95%CI, 95% confidence intervals.